This methodological assessment used data from a randomized controlled noninferiority trial of patients with low-risk prostate cancer, conducted by NRG Oncology (ClinicalTrials.gov identifier: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback